Mass-drug administration curbs scabies for asylum seekers in the Netherlands

May 17, 2018, Public Library of Science

In a new article published in PLOS Neglected Tropical Diseases, Sofanne J. Ravensbergen of the University of Groningen, and colleagues, found that a scabies intervention program (SIP) was effective in reducing the severity of scabies when introduced to the newly arrived Eritrean and Ethiopian asylum seekers who volunteered to take part in the program.

Scabies, a skin infestation caused by the tiny mite Sarcoptes scabiei burrowing into the outer layer of skin, is a major risk factor in the development of bacterial skin infections, relentless itching, and rashes. Nurses and physicians working at national receptions centers in the Netherlands noticed the Eritrean and Ethiopian were particularly affected by scabies. In response, the Dutch national reception centers introduced a SIP for these seekers from January 2014 to March 2016. The authors of this study found that, before the SIP was initiated, 12.3% of 462 asylum seekers developed complications of scabies. Once the SIP was launched, only 4.6% of 897 asylum seekers showed signs of scabies complications.

The researchers were unable to determine how long these volunteer asylum seekers stayed in the asylum centers that implemented the SIP, which made it impossible to calculate the exact incidence rate of scabies. Additionally, since asylum seekers frequently relocate to other asylum centers without a SIP, reinfestations could occur through contact with untreated contagious individuals. However, the number of scabies reinfestations after treatment and the number of complicated forms of scabies were both reduced after introduction of the program.

"Controlling scabies amongst asylum seekers is important to reduce the risk of complicated cases and to prevent the spread of scabies amongst asylum seekers at asylum centres in the Netherlands," notes the authors, "The centralized health care system for asylum seekers that is used in the Netherlands allows accurate follow up of asylum seekers and provides unique retrospective data on the programme."

Explore further: Got scabies? Here's what to do

More information: Beeres DT, Ravensbergen SJ, Heidema A, Cornish D, Vonk M, et al. (2018) Efficacy of ivermectin mass-drug administration to control scabies in asylum seekers in the Netherlands: A retrospective cohort study between January 2014 - March 2016. PLOS Neglected Tropical Diseases 12(5): e0006401. doi.org/10.1371/journal.pntd.0006401

Related Stories

Got scabies? Here's what to do

December 9, 2017
(HealthDay)—If you or a family member develops scabies, you need to take immediate action, a dermatologist advises.

Study finds specialist support is lacking for LGBT asylum seekers

November 7, 2014
Lesbian, gay, bisexual and transgender (LGBT) asylum seekers – including those living with HIV – face a lack of specialist support and services in the UK, according to a study by the University of Liverpool.

Failed child asylum claims in the UK

June 5, 2014
Research from the University raises concerns that many young people who are refused asylum in the UK are not being advised appropriately and are not appealing against decisions even when they have an arguable case.

Recommended for you

Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism

December 11, 2018
Treatment with active vitamin D did not decrease cardiovascular events in kidney patients undergoing hemodialysis, according to a research group in Japan. They have reported their research results in the December 11 issue ...

Human antibody discovery could save lives from fungal killer

December 11, 2018
A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

Dialysis patients at risk of progressive brain injury

December 10, 2018
Kidney dialysis can cause short-term 'cerebral stunning' and may be associated with progressive brain injury in those who receive the treatment for many years. For many patients with kidney failure awaiting a kidney transplant ...

Silicosis is on the rise, but is there a therapeutic target?

December 6, 2018
Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, ...

PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds

December 6, 2018
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain—or tuberculosis meningitis (TBM)—is often deadly, always hard to treat, and a particular ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.